BEXIMCO PHARMAGDR Gross Profit vs. Return On Asset
| R2WA Stock | EUR 0.41 0.00 0.00% |
For BEXIMCO PHARMAGDR profitability analysis, we use financial ratios and fundamental drivers that measure the ability of BEXIMCO PHARMAGDR to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well BEXIMCO PHARMAGDR REGS utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between BEXIMCO PHARMAGDR's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of BEXIMCO PHARMAGDR REGS over time as well as its relative position and ranking within its peers.
BEXIMCO |
BEXIMCO PHARMAGDR REGS Return On Asset vs. Gross Profit Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining BEXIMCO PHARMAGDR's current stock value. Our valuation model uses many indicators to compare BEXIMCO PHARMAGDR value to that of its competitors to determine the firm's financial worth. BEXIMCO PHARMAGDR REGS is rated second in gross profit category among its peers. It is rated third in return on asset category among its peers . The ratio of Gross Profit to Return On Asset for BEXIMCO PHARMAGDR REGS is about 238,452,490,728 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the BEXIMCO PHARMAGDR's earnings, one of the primary drivers of an investment's value.BEXIMCO Return On Asset vs. Gross Profit
Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
BEXIMCO PHARMAGDR |
| = | 15.71 B |
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
BEXIMCO PHARMAGDR |
| = | 0.0659 |
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
BEXIMCO Return On Asset Comparison
BEXIMCO PHARMAGDR is rated second in return on asset category among its peers.
BEXIMCO PHARMAGDR Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in BEXIMCO PHARMAGDR, profitability is also one of the essential criteria for including it into their portfolios because, without profit, BEXIMCO PHARMAGDR will eventually generate negative long term returns. The profitability progress is the general direction of BEXIMCO PHARMAGDR's change in net profit over the period of time. It can combine multiple indicators of BEXIMCO PHARMAGDR, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Beximco Pharmaceuticals Limited manufactures and markets generic pharmaceutical formulation products and active pharmaceutical ingredients. Beximco Pharmaceuticals Limited was founded in 1976 and is headquartered in Dhaka, Bangladesh. Beximco Pharmaceuticals operates under Drug Manufacturers - Major classification in Germany and traded on Frankfurt Stock Exchange.
BEXIMCO Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on BEXIMCO PHARMAGDR. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of BEXIMCO PHARMAGDR position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the BEXIMCO PHARMAGDR's important profitability drivers and their relationship over time.
Use BEXIMCO PHARMAGDR in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if BEXIMCO PHARMAGDR position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BEXIMCO PHARMAGDR will appreciate offsetting losses from the drop in the long position's value.BEXIMCO PHARMAGDR Pair Trading
BEXIMCO PHARMAGDR REGS Pair Trading Analysis
The ability to find closely correlated positions to BEXIMCO PHARMAGDR could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace BEXIMCO PHARMAGDR when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back BEXIMCO PHARMAGDR - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling BEXIMCO PHARMAGDR REGS to buy it.
The correlation of BEXIMCO PHARMAGDR is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as BEXIMCO PHARMAGDR moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if BEXIMCO PHARMAGDR REGS moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for BEXIMCO PHARMAGDR can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your BEXIMCO PHARMAGDR position
In addition to having BEXIMCO PHARMAGDR in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Large Blend Funds Thematic Idea Now
Large Blend Funds
Fund or Etfs that invest in stocks of large organizations that have characteristics of both growth and value companies. The Large Blend Funds theme has 44 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Large Blend Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in BEXIMCO Stock
To fully project BEXIMCO PHARMAGDR's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of BEXIMCO PHARMAGDR REGS at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include BEXIMCO PHARMAGDR's income statement, its balance sheet, and the statement of cash flows.